Pro Feature
Upgrade to Pro to access CMS Part B ASP pricing data and other premium pharma intelligence.
Upgrade to Pro — $25/moWhy This Matters for Your Career
Pfizer is hiring 2 roles related to this product
BLEOMYCIN SULFATE (bleomycin) by Pfizer is mechanism of action although the exact mechanism of action of bleomycin is unknown, available evidence indicates that the main mode of action is the inhibition of dna synthesis with some evidence of lesser inhibition of rna and protein synthesis. Approved for lymphoma, lymphoma. First approved in 2000.
Drug data last refreshed 19h ago
Mechanism of Action Although the exact mechanism of action of bleomycin is unknown, available evidence indicates that the main mode of action is the inhibition of DNA synthesis with some evidence of lesser inhibition of RNA and protein synthesis. Bleomycin is known to cause single, and to a lesser…
Low-Dose Propranolol and Bleomycin for Infantile Hemangioma (IH)
Comparison of Therapeutic Efficacy Between Intralesional Bleomycin and Cryotherapy in Plantar Warts
Bleomycin Jet Injections in Keloids
Evaluating Quality of Life in Patients With AIDS-Associated Kaposi Sarcoma Treated With Bleomycin and Vincristine
Electrochemoterapy With Bleomycin for the Treatment of Unresectable Pancreatic Cancer
Worked on BLEOMYCIN SULFATE at Pfizer? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Upgrade to Pro to access CMS Part B ASP pricing data and other premium pharma intelligence.
Upgrade to Pro — $25/moPfizer is hiring 2 roles related to this product